Back
Aligos Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
ALGS
Aligos Therapeutics
Last Price:
18.29
Seasonality Move:
0%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- The current trend is moderately bullish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.
Aligos Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.35 | Sell |
| 20-day SMA: | 13 | Buy |
| 50-day SMA: | 10.58 | Buy |
| 200-day SMA: | 15.33 | Buy |
| 8-day EMA: | 17.46 | Buy |
| 20-day EMA: | 14.3 | Buy |
| 50-day EMA: | 12.12 | Buy |
| 200-day EMA: | 14.69 | Buy |
Aligos Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.75 | Buy |
| Relative Strength Index (14 RSI): | 71.63 | Buy |
| Chaikin Money Flow: | -318502 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.19 - 16.51) | Buy |
| Bollinger Bands (100): | (8.55 - 14.97) | Buy |
Aligos Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aligos Therapeutics Stock
Is Aligos Therapeutics Stock a Buy?
- Aligos Therapeutics share price is 18.20 while ALGS 8-day simple moving average is 18.35, which is a Sell signal.
- The stock price of ALGS is 18.20 while Aligos Therapeutics 20-day SMA is 13.00, which makes it a Buy.
- Aligos Therapeutics 50-day simple moving average is 10.58 while ALGS share price is 18.20, making it a Buy technically.
- ALGS stock price is 18.20 and Aligos Therapeutics 200-day simple moving average is 15.33, creating a Buy signal.
ALGS Technical Analysis vs Fundamental Analysis
Buy
55
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy or a Sell?
-
Aligos Therapeutics stock is rated a Buy
The current Aligos Therapeutics [ALGS] share price is $18.20. The Score for ALGS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Aligos Therapeutics Stock Info
Market Cap:
65.3M
Price in USD:
18.20
Share Volume:
471.77K
Aligos Therapeutics 52-Week Range
52-Week High:
30.00
52-Week Low:
6.76
Buy
55
Aligos Therapeutics (ALGS)
is a Buy
Aligos Therapeutics Share Price Forecast
-
What is the Aligos Therapeutics stock price today?
The Aligos Therapeutics stock price is 18.20 USD today. -
Will ALGS stock go up or go down?
Aligos Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aligos Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aligos Therapeutics is not overvalued.
Is Aligos Therapeutics Stock a Buy?
- Aligos Therapeutics share price is 18.20 while ALGS 8-day exponential moving average is 17.46, which is a Buy signal.
- The stock price of ALGS is 18.20 while Aligos Therapeutics 20-day EMA is 14.30, which makes it a Buy.
- Aligos Therapeutics 50-day exponential moving average is 12.12 while ALGS share price is 18.20, making it a Buy technically.
- ALGS stock price is 18.20 and Aligos Therapeutics 200-day simple moving average is 14.69, creating a Buy signal.
Fundamental Analysis of Aligos Therapeutics
Is Aligos Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Technical Analysis of Aligos Therapeutics
Should I short Aligos Therapeutics stock?
- ALGS Moving Average Covergence Divergence (MACD) indicator is 2.75, suggesting Aligos Therapeutics is a Buy
- Aligos Therapeutics Relative Strength Index (RSI) is 71.63, which suggest Aligos Therapeutics is overbought
- The Bollinger Bands (25) for Aligos Therapeutics is (7.19 - 16.51), which suggest Aligos Therapeutics is a Buy
- The Bollinger Bands (100) for Aligos Therapeutics is (8.55 - 14.97), which suggest Aligos Therapeutics is a Buy
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.